Search the Newsreel

Biodesix Diagnostic Testing Revenue Climbs 42% as Tests Reach 20,900

Biodesix reported strong Q2 2026 results, with total revenue increasing 34% to $26.9 million, driven by a 42% rise in Diagnostic Testing revenue. Test volumes grew by 38% to 20,900, contributing to an 82% gross margin. Despite a net loss of $7.3 million, the …

Biodesix (Nasdaq: BDSX) grows Q2 2026 revenue 34% to $26.9M

Biodesix (Nasdaq: BDSX) reported a 34% year-over-year revenue increase in Q2 2026, reaching $26.9 million, driven by a 42% rise in Diagnostic Testing revenue. Despite this growth and an improved gross margin of 82%, the company still reported a net loss of $7.3 million …

BIODESIX Inc Q2 2026: Revenue $26.86M, EPS $(0.71) — 10-Q Summary

BIODESIX Inc (BDSX) reported its Q2 2026 results, showing a 34% year-over-year revenue increase to $26.86 million and a narrowed net loss of $7.27 million, or $(0.71) per share, compared to $(1.56) in Q2 2025. The company's diagnostic testing revenue grew by 42%, driven …

Q3 EPS Estimates for AngioDynamics Reduced by Zacks Research

Royal Bank of Canada Lowers Stake in Diodes Incorporated $DIOD

Royal Bank of Canada reduced its stake in Diodes Incorporated (NASDAQ:DIOD) by 4.7% in the first quarter of 2026, selling 17,721 shares and retaining 360,138 shares valued at approximately $24.6 million. Despite some insider selling, institutional investors collectively own 99.23% of the company. Analysts …

AngioDynamics, Inc. $ANGO Shares Purchased by Lazard Asset Management LLC

Lazard Asset Management LLC significantly increased its stake in AngioDynamics, Inc. (NASDAQ:ANGO) by 1,328.2% during the first quarter, now owning 154,578 shares valued at $1.76 million. This comes as AngioDynamics exceeded Q1 earnings expectations, reporting an adjusted loss of $0.07 per share on $86.61 …

Biodesix (NASDAQ: BDSX) lifts lung test revenue and raises $23.9M equity

Diodes (DIOD) Earnings Date and Reports 2026

Diodes Incorporated (NASDAQ: DIOD) lifts Q2 2026 sales and cash reserves

Biodesix (NASDAQ:BDSX) Announces Earnings Results

Diodes (DIOD) Stock May Be Cheap As Earnings Keep Supporting Value

Senior Vice President of Regulatory Affairs Warren Nighan Sold A Bunch Of Shares In AngioDynamics

Warren Nighan, Senior Vice President of Regulatory Affairs at AngioDynamics, recently sold US$344k worth of stock, representing 27% of his holding. While insiders did buy some shares in the last year, the overall trend points to more selling than buying. This sale, the largest …

Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference

Biodesix, Inc. announced that its leadership team will participate in Canaccord Genuity's 46th Annual Growth Conference. They will present in a fireside chat and hold in-person investor meetings from August 11-12, 2026. The fireside chat is scheduled for August 12, 2026, at 3:30 PM …

Biodesix leadership's Aug. 12 fireside chat will be webcast live

Biodesix (Nasdaq: BDSX) announced that its leadership team will participate in Canaccord Genuity’s 46th Annual Growth Conference from August 11-12, 2026. The team will host a fireside chat on August 12, 2026, at 3:30 PM ET, which will be webcast live and available for …

Biodesix Inc expected to post a loss of 90 cents a share - Earnings Preview

Biodesix Inc is projected to report a loss of 90 cents per share. This information comes from a Refinitiv earnings preview. The full article is available on TradingView, which aggregates news from various sources including Reuters.

Healthcare of Ontario Pension Plan Trust Fund Lowers Stake in Diodes Incorporated $DIOD

The Healthcare of Ontario Pension Plan Trust Fund significantly reduced its stake in Diodes Incorporated (NASDAQ:DIOD) by 78% in the first quarter, selling 43,503 shares and retaining 12,286 shares valued at $839,000. Despite this reduction, institutional investors and hedge funds collectively own 99.23% of …

AngioDynamics (NASDAQ: ANGO) insider plans $344K sale of equity awards

An insider at AngioDynamics (NASDAQ: ANGO) plans to sell 23,370 shares of common stock, valued at approximately $344,004.06. This proposed sale involves equity awards, specifically restricted stock from 2020 and performance share units from 2021, and will be conducted through Morgan Stanley Smith Barney …

AngioDynamics (ANGO) SVP Warren Nighan Sells 23,370 Shares

Warren Nighan, SVP of Quality and Regulatory at AngioDynamics (ANGO), sold 23,370 shares for approximately $344,006. This transaction occurred on July 30, 2026, and leaves him with 64,745 shares. While the stock is deemed "Significantly Overvalued" by GuruFocus's GF Value model, institutional investors (gurus) …

Form 4 AngioDynamics Inc For: 31 July By Investing.com

This article reports on a Form 4 filing for AngioDynamics Inc. for July 31st. It provides various financial market data, including indices, commodities, bonds, and shares, along with trending stocks and investment strategy suggestions. The core content is the announcement of the Form 4 …

Angiodynamics SVP Warren Nighan Jr sells $344,006 in stock

Warren Nighan Jr., Senior Vice President at AngioDynamics Inc., sold 23,370 shares of company stock for a total of $344,006. This transaction occurred as the stock trades near its 52-week high after a 67% gain, with InvestingPro analysis suggesting it is overvalued. Despite the …

Diodes Inc (DIOD) Valuation: PE, PB & Fair Value Analysis

Diodes Inc (DIOD) has a current valuation score of 8.56, placing it 30th out of 105 companies in the Semiconductors & Semiconductor Equipment industry. The company's P/E ratio stands at 44.35, which is significantly lower than its recent high but considerably higher than its …

AngioDynamics Inc (ANGO) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for AngioDynamics Inc (ANGO), highlighting its current risk score, industry ranking, and beta value. It details the stock's volatility, maximum drawdown, and return metrics over various periods, emphasizing its tendency to underperform in up-trending markets and experience smaller …

AngioDynamics Inc (ANGO) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of AngioDynamics Inc (ANGO), stating its current valuation score is 7.33, ranking 152 out of 199 in the Healthcare Equipment & Supplies industry. The company's P/E ratio is -19.48, which is significantly below its recent high. It also …

Diodes Incorporated (NASDAQ:DIOD) Receives Average Recommendation of "Moderate Buy" from Analysts

Diodes Incorporated (NASDAQ:DIOD) has received an average recommendation of "Moderate Buy" from five research firms, with three analysts assigning a buy rating and two a hold rating. The average 12-month target price for the semiconductor company is $113.00. Recent analyst reports include a downgrade …

Biodesix Inc (BDSX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Biodesix Inc (BDSX), noting its current price momentum score and suggesting it's suitable for range-bound swing trading with resistance at 24.41 and support at 18.59. It details various technical indicators like MACD, RSI, and moving averages (MA5 …

Lazard Asset Management LLC Sells 37,105 Shares of Diodes Incorporated $DIOD

Lazard Asset Management LLC reduced its stake in Diodes Incorporated (NASDAQ:DIOD) by 18.4% in the first quarter, selling 37,105 shares and retaining 164,673 shares valued at approximately $11.24 million. Other institutional investors have also adjusted their positions, and although some analysts have downgraded the …

ANGO|AngioDynamics Inc|Price:14.630|Chg%:+0.290

This article provides a comprehensive stock analysis of AngioDynamics Inc (ANGO), highlighting its relatively healthy fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. It notes high institutional ownership and a recent "Buy" rating from analysts with an expected …

AngioDynamics Number of Employees 2026 | Employee Count & Headcount Data

AngioDynamics, Inc. (ANGO) has 627 employees worldwide as of March 2026, marking a 2.8% decline since 2023 but a 0.1% increase year-over-year. The company is actively hiring, with 58 job postings in 2026, a 39.2% increase from 2025. Its workforce is concentrated in North …

Diodes (DIOD) Expected to Announce Earnings on Wednesday

Diodes (DIOD) is anticipated to release its Q2 2026 earnings before market open on Wednesday, August 5th, with analysts projecting earnings of $0.627 per share and revenue of $436.6 million. The company exceeded expectations in its previous quarter, and its shares are currently trading …

Biodesix (BDSX) to Post Earnings on Wednesday

Biodesix (BDSX) is scheduled to release its Q2 2026 earnings after market close on Wednesday, August 5th. Analysts anticipate a loss of $0.86 per share on revenue of approximately $26.03 million. In the previous quarter, the company surpassed estimates by reporting a loss of …

Diodes Number of Employees 2026 | Employee Count & Headcount Data

Diodes, Inc. (NASDAQ: DIOD) has approximately 8,020 employees worldwide as of March 2026, marking a 0.7% increase year-over-year. The company's workforce is primarily concentrated in China, Taiwan, and the United Kingdom, with a global average salary of $52,559. Diodes is actively hiring, with 46 …

Oxford BioDynamics Plc Revenue Breakdown – LSE:OBD

AngioDynamics Inc (ANGO) Institutional Confidence

AngioDynamics Inc (ANGO) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 93.94%, a decrease of 11.97% quarter-over-quarter. Steven Cohen is the largest institutional shareholder, holding 3.06 million shares, despite a …

DIOD|Diodes Inc|Price:80.290|Chg%:-5.610

Diodes Inc (DIOD) has a TradingKey Stock Score indicating very healthy fundamentals and high growth potential, despite a recent weak stock market performance. The company's valuation is considered fairly valued within the Semiconductors & Semiconductor Equipment industry, and institutional ownership is very high. Analysts …

Biodesix, Inc. Revenue Breakdown – NASDAQ:BDSX

This document provides a revenue breakdown for Biodesix, Inc. (NASDAQ: BDSX), accessible through TradingView. It offers an overview of the company's financial information, including statements, statistics, dividends, earnings, and segment performance by source and country. The information is sourced from ICE Data Services, FactSet, …

Evan Yu elected to Diodes board, effective Aug 1

Diodes elected Evan Yu to its Board of Directors, effective August 1, 2026. Yu is a seasoned semiconductor executive with extensive global leadership experience, having previously served as SVP, Worldwide Power Products at Diodes, CEO of Commit Inc., and held positions at Texas Instruments …